PortalPublikationenEfficacy and safety of ixekizumab after switching from fumar...

Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment

Standard

Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment. / Leutz, A; Pinter, A; Thaçi, D; Augustin, M; Schuster, C; Fotiou, K; Hundemer, H P; Saure, D; Mrowietz, U; Reich, K.

in: BRIT J DERMATOL, Jahrgang 184, Nr. 3, 03.2021, S. 548-550.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Leutz, A, Pinter, A, Thaçi, D, Augustin, M, Schuster, C, Fotiou, K, Hundemer, HP, Saure, D, Mrowietz, U & Reich, K 2021, 'Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment', BRIT J DERMATOL, Jg. 184, Nr. 3, S. 548-550. https://doi.org/10.1111/bjd.19558

APA

Leutz, A., Pinter, A., Thaçi, D., Augustin, M., Schuster, C., Fotiou, K., Hundemer, H. P., Saure, D., Mrowietz, U., & Reich, K. (2021). Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment. BRIT J DERMATOL, 184(3), 548-550. https://doi.org/10.1111/bjd.19558

Vancouver

Leutz A, Pinter A, Thaçi D, Augustin M, Schuster C, Fotiou K et al. Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment. BRIT J DERMATOL. 2021 Mär;184(3):548-550. https://doi.org/10.1111/bjd.19558

Bibtex

@article{e654a9b70def401e935630fc1c557fbe,
title = "Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis na{\"i}ve to systemic treatment",
author = "A Leutz and A Pinter and D Tha{\c c}i and M Augustin and C Schuster and K Fotiou and Hundemer, {H P} and D Saure and U Mrowietz and K Reich",
year = "2021",
month = mar,
doi = "10.1111/bjd.19558",
language = "English",
volume = "184",
pages = "548--550",
journal = "BRIT J DERMATOL",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment

AU - Leutz, A

AU - Pinter, A

AU - Thaçi, D

AU - Augustin, M

AU - Schuster, C

AU - Fotiou, K

AU - Hundemer, H P

AU - Saure, D

AU - Mrowietz, U

AU - Reich, K

PY - 2021/3

Y1 - 2021/3

U2 - 10.1111/bjd.19558

DO - 10.1111/bjd.19558

M3 - Other (editorial matter etc.)

C2 - 32940343

VL - 184

SP - 548

EP - 550

JO - BRIT J DERMATOL

JF - BRIT J DERMATOL

SN - 0007-0963

IS - 3

ER -